No increased risk of Kaposi sarcoma relapse in patients with controlled HIV‐1 infection after switching protease inhibitor‐based antiretroviral therapy.
Saved in:
| Title: | No increased risk of Kaposi sarcoma relapse in patients with controlled HIV‐1 infection after switching protease inhibitor‐based antiretroviral therapy. |
|---|---|
| Authors: | Lajaunie, Rébecca1, Cuzin, Lise2, Palich, Romain3, Makinson, Alain4, Bani‐Sadr, Firouzé5, Duvivier, Claudine6, Arvieux, Cedric7, Rey, David8, Poizot‐Martin, Isabelle9, Delpierre, Cyril10, Delobel, Pierre11, Martin‐Blondel, Guillaume11 martin-blondel.g@chu-toulouse.fr, Chirouze, C., Drobacheff‐Thiébaut, C., Foltzer, A., Bouiller, K., Hustache‐ Mathieu, L., Lepiller, Q., Bozon, F., Babre, O |
| Source: | HIV Medicine. Mar2022, Vol. 23 Issue 3, p301-306. 6p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14642662 |
|---|---|
| DOI: | 10.1111/hiv.13168 |
